← Health & Life Sciences investors
Investor profile · The Hype List
OrbiMed Advisors
The Global Healthcare Investor Ranked No. 1 in Biotech Venture
Visit websiteWhy it made the list
Current 2026 top-ranking biotech venture signal with continuing deployment across healthcare companies.
Proof point
OrbiMed's official site reported on Feb. 27, 2026 that it had reached No. 1 on the Endpoints Top 100 list of biotech venture investors; on Sep. 17, 2026 it co-led Altis Labs' $25M Series A.
Sources: orbimed.com, orbimed.com, orbimed.com
- Industry focus
- Health; Pharmaceutical; Medical Devices; Diagnostics; Digital Health; Healthcare Providers & Services
- Technology focus
- Computational Biology; AI; Hardware; Software
- Stage
- Early Stage & Growth Equity Investments
- Geography
- Global
- Category
- The Hype List
Team
MP
in LinkedInMona Ashiya, PhD
General Partner
DM
in LinkedInDavid Bonita, MD
General Partner
TP
in LinkedInTal Zaks, MD, PhD
Partner
Is this investor a fit for you?
Assess your investment case and see which investors actually match your company.
Get Investor Ready